Form 6-K HUTCHMED (China) Ltd For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
July 30, 2026 7:19 AM EDT
2026-06-300001648257--12-312026Q2false00016482572026-01-012026-06-300001648257us-gaap:CommonStockMember2026-01-012026-06-300001648257us-gaap:CommonStockMember2025-01-012025-06-300001648257us-gaap:RetainedEarningsMember2026-06-300001648257us-gaap:ParentMember2026-06-300001648257us-gaap:NoncontrollingInterestMember2026-06-300001648257us-gaap:AdditionalPaidInCapitalMember2026-06-300001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-300001648257us-gaap:RetainedEarningsMember2025-12-310001648257us-gaap:ParentMember2025-12-310001648257us-gaap:NoncontrollingInterestMember2025-12-310001648257us-gaap:AdditionalPaidInCapitalMember2025-12-310001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001648257us-gaap:RetainedEarningsMember2025-06-300001648257us-gaap:ParentMember2025-06-300001648257us-gaap:NoncontrollingInterestMember2025-06-300001648257us-gaap:AdditionalPaidInCapitalMember2025-06-300001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001648257us-gaap:RetainedEarningsMember2024-12-310001648257us-gaap:ParentMember2024-12-310001648257us-gaap:NoncontrollingInterestMember2024-12-310001648257us-gaap:AdditionalPaidInCapitalMember2024-12-310001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001648257hcm:HCMLShareOptionSchemeMember2024-01-012024-12-310001648257hcm:HCMLShareOptionSchemeMember2024-12-310001648257hcm:HCMLShareOptionSchemeMember2025-01-012025-12-310001648257hcm:HCMLShareOptionSchemeMember2025-12-310001648257srt:MaximumMemberhcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257hcm:HCMLShareOptionSchemeMember2015-04-242015-04-240001648257hcm:LongTermIncentivePlanMember2025-01-012025-12-310001648257hcm:LongTermIncentivePlanMember2024-12-310001648257hcm:AwardsVestingInFourYearsMemberhcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257hcm:ExecutiveDirectorMemberhcm:HCMLShareOptionSchemeMember2025-06-012025-06-300001648257us-gaap:OtherNoncurrentLiabilitiesMember2026-06-300001648257hcm:OtherPayablesAccrualsAndAdvanceReceiptsMember2026-06-300001648257us-gaap:OtherNoncurrentLiabilitiesMember2025-12-310001648257hcm:OtherPayablesAccrualsAndAdvanceReceiptsMember2025-12-310001648257us-gaap:RelatedPartyMemberhcm:OtherVenturesSegmentMember2026-01-012026-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OtherVenturesSegmentMember2026-01-012026-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:RelatedPartyTransactionSalesOfGoodsMemberus-gaap:EquityMethodInvesteeMember2026-01-012026-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:OtherCollaborationLicensingRevenueMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257hcm:OtherCollaborationLicensingRevenueMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:MarketedProductsMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:GoodsDistributionMemberhcm:OtherVenturesSegmentMember2026-01-012026-06-300001648257hcm:CommercializationServicesMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257us-gaap:RelatedPartyMember2026-01-012026-06-300001648257us-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257hcm:UnitedStatesAndOthersMember2026-01-012026-06-300001648257hcm:OtherVenturesSegmentMember2026-01-012026-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMember2026-01-012026-06-300001648257hcm:OtherCollaborationLicensingRevenueMember2026-01-012026-06-300001648257hcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:MarketedProductsMember2026-01-012026-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMember2026-01-012026-06-300001648257hcm:GoodsDistributionMember2026-01-012026-06-300001648257hcm:CustomerMember2026-01-012026-06-300001648257hcm:CustomerBMember2026-01-012026-06-300001648257hcm:CommercializationServicesMember2026-01-012026-06-300001648257hcm:CollaborationResearchAndDevelopmentMember2026-01-012026-06-300001648257country:CN2026-01-012026-06-300001648257us-gaap:RelatedPartyMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:RelatedPartyTransactionSalesOfGoodsMemberus-gaap:EquityMethodInvesteeMember2025-01-012025-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:OtherCollaborationLicensingRevenueMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:OtherCollaborationLicensingRevenueMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:MarketedProductsMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:GoodsDistributionMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257hcm:CommercializationServicesMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257us-gaap:RelatedPartyMember2025-01-012025-06-300001648257us-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:UnitedStatesAndOthersMember2025-01-012025-06-300001648257hcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMember2025-01-012025-06-300001648257hcm:OtherCollaborationLicensingRevenueMember2025-01-012025-06-300001648257hcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:MarketedProductsMember2025-01-012025-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMember2025-01-012025-06-300001648257hcm:GoodsDistributionMember2025-01-012025-06-300001648257hcm:CustomerMember2025-01-012025-06-300001648257hcm:CustomerBMember2025-01-012025-06-300001648257hcm:CommercializationServicesMember2025-01-012025-06-300001648257hcm:CollaborationResearchAndDevelopmentMember2025-01-012025-06-300001648257country:CN2025-01-012025-06-300001648257hcm:CollaborativeArrangementsMember2026-01-012026-06-300001648257hcm:CollaborativeArrangementsMember2025-01-012025-06-300001648257hcm:FixedAssetLoanFacilityMember2026-01-012026-06-300001648257hcm:FixedAssetLoanFacilityMember2025-01-012025-12-310001648257us-gaap:EquityMethodInvesteeMember2026-01-012026-06-300001648257us-gaap:EquityMethodInvesteeMember2025-01-012025-06-300001648257us-gaap:RetainedEarningsMember2026-01-012026-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-252025-04-250001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-06-300001648257hcm:RelatedPartyTransactionManagementServiceMembersrt:AffiliatedEntityMember2026-01-012026-06-300001648257hcm:RelatedPartyTransactionManagementServiceMembersrt:AffiliatedEntityMember2025-01-012025-06-300001648257us-gaap:CapitalAdditionsMember2026-01-012026-06-300001648257hcm:ShortTermWorkingCapitalLoanFacilityMember2025-10-310001648257hcm:FixedAssetLoanFacilityMember2021-10-310001648257hcm:ShortTermWorkingCapitalLoanFacilityMember2026-06-300001648257hcm:FixedAssetLoanFacilityMember2026-06-300001648257hcm:ShortTermWorkingCapitalLoanFacilityMember2025-12-310001648257hcm:FixedAssetLoanFacilityMember2025-12-310001648257hcm:ImagenebioIncMember2026-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-12-310001648257hcm:ImagenebioIncMember2025-12-310001648257hcm:HCMLShareOptionSchemeMember2026-06-300001648257country:HK2026-01-012026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2026-01-012026-06-300001648257hcm:CorporateAndReconcilingItemsMember2026-01-012026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2025-01-012025-06-300001648257hcm:LongTermIncentivePlanMember2026-06-300001648257hcm:LongTermIncentivePlanMember2025-12-310001648257hcm:FixedAssetLoanFacilityMember2021-10-012021-10-310001648257hcm:ShortTermWorkingCapitalLoanFacilityMemberhcm:OneYearChinaLoanPrimeRateMember2025-10-012025-10-310001648257hcm:FixedAssetLoanFacilityMemberhcm:FiveYearChinaLoanPrimeRateMember2021-10-012021-10-310001648257us-gaap:ForeignTaxJurisdictionOtherMember2026-01-012026-06-300001648257us-gaap:ForeignTaxJurisdictionOtherMember2025-01-012025-06-300001648257country:CN2025-01-012025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2026-01-012026-06-300001648257us-gaap:ProductMemberus-gaap:RelatedPartyMember2026-01-012026-06-300001648257us-gaap:ProductMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2026-01-012026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:CommercializationServicesMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2025-01-012025-06-300001648257us-gaap:ProductMemberus-gaap:RelatedPartyMember2025-01-012025-06-300001648257us-gaap:ProductMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:CommercializationServicesMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:OtherVenturesSegmentMember2026-06-300001648257hcm:OncologyOrImmunologySegmentMember2026-06-300001648257hcm:OtherVenturesSegmentMember2025-12-310001648257hcm:OncologyOrImmunologySegmentMember2025-12-310001648257us-gaap:CommonStockMember2026-06-300001648257us-gaap:CommonStockMember2025-12-310001648257us-gaap:CommonStockMember2025-06-300001648257us-gaap:CommonStockMember2024-12-310001648257srt:OtherCurrencyMember2026-06-300001648257currency:USD2026-06-300001648257currency:HKD2026-06-300001648257currency:GBP2026-06-300001648257currency:CNY2026-06-300001648257srt:OtherCurrencyMember2025-12-310001648257currency:USD2025-12-310001648257currency:HKD2025-12-310001648257currency:GBP2025-12-310001648257currency:CNY2025-12-310001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2026-06-300001648257hcm:UnitedStatesAndOthersMember2026-06-300001648257hcm:CorporateAndReconcilingItemsMember2026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2025-12-310001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2025-12-310001648257hcm:UnitedStatesAndOthersMember2025-12-310001648257hcm:CorporateAndReconcilingItemsMember2025-12-3100016482572025-06-3000016482572024-12-310001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:LongTermIncentivePlanMember2026-01-012026-06-300001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:LongTermIncentivePlanMember2026-01-012026-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257us-gaap:CostOfSalesMemberhcm:LongTermIncentivePlanMember2026-01-012026-06-300001648257us-gaap:CostOfSalesMemberhcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:LiabilityMember2026-01-012026-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-06-300001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257us-gaap:CostOfSalesMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257us-gaap:CostOfSalesMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:LiabilityMember2025-01-012025-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001648257hcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257us-gaap:NoncontrollingInterestMember2026-01-012026-06-300001648257us-gaap:NoncontrollingInterestMember2025-01-012025-06-300001648257hcm:NotLaterThanThreeMonthsMemberus-gaap:NonrelatedPartyMember2026-06-300001648257hcm:LaterThanOneYearMemberus-gaap:NonrelatedPartyMember2026-06-300001648257hcm:BetweenThreeMonthsToSixMonthsMemberus-gaap:NonrelatedPartyMember2026-06-300001648257hcm:BetweenSixMonthsToOneYearMemberus-gaap:NonrelatedPartyMember2026-06-300001648257hcm:NotLaterThanThreeMonthsMemberus-gaap:NonrelatedPartyMember2025-12-310001648257hcm:LaterThanOneYearMemberus-gaap:NonrelatedPartyMember2025-12-310001648257hcm:BetweenThreeMonthsToSixMonthsMemberus-gaap:NonrelatedPartyMember2025-12-310001648257hcm:BetweenSixMonthsToOneYearMemberus-gaap:NonrelatedPartyMember2025-12-310001648257hcm:SeroquelMember2026-06-300001648257hcm:NotLaterThanThreeMonthsMember2026-06-300001648257hcm:LaterThanOneYearMember2026-06-300001648257hcm:BetweenThreeMonthsToSixMonthsMember2026-06-300001648257hcm:BetweenSixMonthsToOneYearMember2026-06-300001648257hcm:NotLaterThanThreeMonthsMember2025-12-310001648257hcm:LaterThanOneYearMember2025-12-310001648257hcm:BetweenThreeMonthsToSixMonthsMember2025-12-310001648257hcm:BetweenSixMonthsToOneYearMember2025-12-310001648257us-gaap:RetainedEarningsMember2025-01-012025-06-300001648257srt:MinimumMember2026-01-012026-06-300001648257srt:MaximumMember2026-01-012026-06-300001648257srt:MinimumMember2025-01-012025-12-310001648257srt:MaximumMember2025-01-012025-12-310001648257us-gaap:ParentMember2026-01-012026-06-300001648257us-gaap:AdditionalPaidInCapitalMember2026-01-012026-06-300001648257hcm:LongTermIncentivePlanMember2026-01-012026-06-300001648257hcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257hcm:AwardsVestingInFourYearsMemberhcm:HCMLShareOptionSchemeMember2026-06-300001648257hcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257hcm:OrdinarySharesOrAmericanDepositaryShareMemberhcm:LongTermIncentivePlanMember2026-01-012026-06-300001648257hcm:OrdinarySharesOrAmericanDepositaryShareMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2026-01-012026-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-01-012025-12-3100016482572025-01-012025-12-310001648257srt:AffiliatedEntityMember2026-01-012026-06-300001648257us-gaap:RelatedPartyMember2026-06-300001648257us-gaap:EquityMethodInvesteeMember2026-06-300001648257srt:AffiliatedEntityMember2026-06-300001648257hcm:NonControllingShareholdersOfSubsidiariesMember2026-06-300001648257us-gaap:RelatedPartyMember2025-12-310001648257us-gaap:EquityMethodInvesteeMember2025-12-310001648257srt:AffiliatedEntityMember2025-12-310001648257hcm:NonControllingShareholdersOfSubsidiariesMember2025-12-310001648257us-gaap:NonrelatedPartyMember2026-06-300001648257us-gaap:NonrelatedPartyMember2025-12-310001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2026-06-300001648257us-gaap:SubsequentEventMember2026-07-0100016482572022-06-2700016482572021-10-212021-10-210001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2026-06-300001648257country:CN2026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2025-12-310001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2025-12-310001648257country:CN2025-12-310001648257hcm:CorporateAndReconcilingItemsMember2025-01-012025-06-300001648257hcm:TwoChinaBasedPrivateEquityFundsMemberhcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-250001648257hcm:ParentCompanyOfCoVenturerMemberhcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-250001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-250001648257country:CN2026-01-012026-06-300001648257hcm:DueFromRelatedPartiesMemberus-gaap:EquityMethodInvesteeMember2026-06-300001648257hcm:DueFromRelatedPartiesMemberus-gaap:EquityMethodInvesteeMember2025-12-310001648257us-gaap:ParentMember2025-01-012025-06-300001648257us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300001648257hcm:NonControllingShareholdersOfSubsidiariesMember2026-01-012026-06-300001648257hcm:NonControllingShareholdersOfSubsidiariesMember2025-01-012025-06-300001648257hcm:TwoChinaBasedPrivateEquityFundsMemberhcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-252025-04-250001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-01-012025-06-3000016482572025-01-012025-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-06-3000016482572026-06-3000016482572025-12-31iso4217:USDiso4217:CNYxbrli:purehcm:itemhcm:directoriso4217:USDxbrli:sharesxbrli:shareshcm:claim
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the Month of July 2026
Commission File Number: 001-37710
HUTCHMED (CHINA) LIMITED
(Translation of registrant’s name into English)
48th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ⌧ Form 40-F ☐
HUTCHMED (CHINA) LIMITED
Form 6-K
EXHIBIT INDEX
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HUTCHMED (CHINA) LIMITED |
| | |
| | |
| By: | /s/ JOHNNY CHENG |
| | Name: | Johnny Cheng |
| | Title: | Chief Financial Officer |
Date: July 30, 2026
ATTACHMENTS / EXHIBITS
EX-99.1
EX-99.2
EX-101.SCH
EX-101.CAL
EX-101.DEF
EX-101.LAB
EX-101.PRE
IDEA: R1.htm
IDEA: R2.htm
IDEA: R3.htm
IDEA: R4.htm
IDEA: R5.htm
IDEA: R6.htm
IDEA: R7.htm
IDEA: R8.htm
IDEA: R9.htm
IDEA: R10.htm
IDEA: R11.htm
IDEA: R12.htm
IDEA: R13.htm
IDEA: R14.htm
IDEA: R15.htm
IDEA: R16.htm
IDEA: R17.htm
IDEA: R18.htm
IDEA: R19.htm
IDEA: R20.htm
IDEA: R21.htm
IDEA: R22.htm
IDEA: R23.htm
IDEA: R24.htm
IDEA: R25.htm
IDEA: R26.htm
IDEA: R27.htm
IDEA: R28.htm
IDEA: R29.htm
IDEA: R30.htm
IDEA: R31.htm
IDEA: R32.htm
IDEA: R33.htm
IDEA: R34.htm
IDEA: R35.htm
IDEA: R36.htm
IDEA: R37.htm
IDEA: R38.htm
IDEA: R39.htm
IDEA: R40.htm
IDEA: R41.htm
IDEA: R42.htm
IDEA: R43.htm
IDEA: R44.htm
IDEA: R45.htm
IDEA: R46.htm
IDEA: R47.htm
IDEA: R48.htm
IDEA: R49.htm
IDEA: R50.htm
IDEA: R51.htm
IDEA: R52.htm
IDEA: R53.htm
IDEA: R54.htm
IDEA: R55.htm
IDEA: R56.htm
IDEA: R57.htm
IDEA: R58.htm
IDEA: R59.htm
IDEA: R60.htm
IDEA: R61.htm
IDEA: R62.htm
IDEA: R63.htm
IDEA: R64.htm
IDEA: R65.htm
IDEA: R66.htm
IDEA: R67.htm
IDEA: R68.htm
IDEA: R69.htm
IDEA: R70.htm
IDEA: R71.htm
IDEA: R72.htm
IDEA: R73.htm
IDEA: R74.htm
IDEA: R75.htm
IDEA: R76.htm
IDEA: R77.htm
IDEA: R78.htm
IDEA: R79.htm
IDEA: R80.htm
IDEA: R81.htm
IDEA: R82.htm
IDEA: R83.htm
IDEA: R84.htm
IDEA: R85.htm
IDEA: R86.htm
IDEA: R87.htm
IDEA: R88.htm
IDEA: R89.htm
IDEA: R90.htm
IDEA: R91.htm
IDEA: FilingSummary.xml
IDEA: MetaLinks.json
IDEA: hcm-20260730x6k_htm.xml
Tweet
Share
E-mail